However, our findings also suggest that there is a risk of missing patients with PVs in SMAD4 or BMPR1A if using these criteria alone: only 60% of the patients with a PV in one of these genes, who had endoscopic investigations, fulfilled the Jass criteria. This evidence concerns the gene BMPR1A and perivascular space measurement.